Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection

British Journal of Rheumatology

Volumn 36, Issue 3, 1997, Pages 360-365

  Ferri, C ^a   La Civita, L ^a   Fazzi, P ^a   Solfanelli, S ^a   Lombardini, F ^a   Begliomini, E ^a   Monti, M ^b   Longombardo, G ^a   Pasero, G ^a   Zignego, A L ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chronic hepatitis; Hepatitis C virus; Lung fibrosis; Rheumatic diseases

Indexed keywords

AUTOANTIBODY; CARBON MONOXIDE; CRYOGLOBULIN; GALLIUM 67; HEPATITIS C ANTIBODY; TRACER; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NEUROPATHY; FEMALE; FIBROSING ALVEOLITIS; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG LAVAGE; LYMPHOCYTE; MALE; NEUTROPHIL; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SPIROMETRY; VIREMIA;

AGED; ANTIBODIES, VIRAL; DYSPNEA; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTES; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RHEUMATIC DISEASES; RHEUMATOID FACTOR; RNA, VIRAL;

EID: 0346089908     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hollander FB. NANBH viruses. In: Hollinger FB, Robinson WS, Purcell RH, Garin JL, Ticehurst J, eds. Viral hepatitis, biological and clinical features, specific diagnosis and prophylaxis. New York: Raven Press, 1991:139-73.
2. Ferri C, Monti M, La Civita L et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
3. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
4. Zignego AL, Ferri C, Monti M et al. Hepatitis C virus as a lymphotropic agent: evidences and pathogenetic implications. Clin Exp Rheumatol 1995;13(suppl. 13): 33-7.
5. Gabrielli A, Manzin A, Candela M et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 1994;97:87-93.
6. Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinemia (review). Eur J Clin Invest 1993;23:399-405.
7. Gorevic PD, Kassab HJ, Levo Y et al. Mixed cryoglobulinemia: clinical aspects and long-term followup of 40 patients. Am J Med 1980;69:287-308.
8. Ferri C, Greco F, Longombardo G et al. Hepatitis C virus antibodies in mixed cryoglobulinaemia patients. Arthritis Rheum 1991;34:1606-10.
9. Bombardieri S, Paoletti P, Ferri C, Di Munno O, Fornai E, Giuntini C. Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979;66:748-56.
10. Salaffi F, Manganelli P, Carotti M, Subiaco S, Cervini C. Mixed cryoglobulinemia: effect of alpha-interferon on subclinical lymphocytes alveolitis. Clin Exp Rheumatol 1996;14:219-20.
11. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
12. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyositis, pulmonary fibrosis, and hepatitis C virus. Arthritis Rheum 1995;38:437-9.
13. Ferri C, La Civita L, Fazzi P, Pasero G, Zignego AL. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 1996;39:1074-5.
14. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994;191:675-80.
15. American Thoracic Society Statement. Snowbird Workshop on standardization of spirometry. Am Rev Respir Dis 1979;119:831-8.
16. Goldman HI, Becklake MR. Respiratory function tests: normal values at medium altitudes and the prediction of normal results. Am Rev Tuberc 1959;79:457-67.
17. Paoletti P, Pistelli G, Fazzi P et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 1986:22:451-9.
18. Cotes JE, Dabbs JM, Hall AM, Axford AT, Laurence K.M. Lung volumes, ventilatory capacity, and transfer factor in healthy British boy and girl twins. Thorax 1973;28:704-15.
19. Line BR, Hunninghake GW, Kedgh BA, Jones AE, Johnston GS, Crystal RG. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage. Am Rev Respir Dis 1981;123:440-6.
20. Solfanelli S, Fazzi P, Deviggiano E, Frediani M, Giuntini C. Gallium-67 uptake quantification in pulmonary sarcoidosis. An implement to Line's method. Sarcoidosis 1991;8:193-202.
21. Reynolds HY. Bronchoalveolar lavage. Am J Rev Respir Dis 1987;135:250-63.
22. Bunn CC, Ghuravi AE, Hughes GRV. Antibodies to extractable nuclear antigens in 173 patients with DNA binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigen observed by counterimmunoelectrophoresis. J Clin Lab Immunol 1982;8:11-7.
23. Zignego AL, Macchia D, Monti M et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-5.
24. Ferri C, Marzo E, Longombardo G et al. Alpha-interferon in mixed cryoglobulinemia patients: a randomized crossover controlled trial. Blood 1993;81:1132-6.
25. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Zignego AL, De Carli M, Monti M et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected subjects. J Med Virol 1995;47:58-64.
27. Gumber S, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
28. Ferri C, Zignego L, Bombardieri S et al. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases, and lymphomas. Clin Exp Rheumatol 1995;13(suppl. 13):135-40.
29. Ferri C, La Civita L, Zignego AL. Extrahepatic manifestations of hepatitis C virus infection. Ann Intern Med 1996;125:344-6.
30. Bernstein RM, Morgan SH, Chapman J et al. Anti-Jo1 antibody: a marker for myositis with interstitial lung disease. Br Med J 1984;289:151-2.
31. Nygard NR, Schwartz BD. Infection and autoimmunity. In: Stollerman GH, LaMont JT, Leonard JJ, Siperstein MD, eds. Advances in internal medicine. Chicago, Mosby-Year Book Inc., 1993;38:337-59.
32. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991;29:474-81.
33. Pinsker KL, Schneyer B, Becker N, Kamholz SL. Usual interstitial pneumonia following Texas A2 influenza infection. Chest 1981;80:123-6.
34. Frazer RG. Pulmonary diseases of unknown origins. In: Frazer RG, Pter Paré JA, Paré PD, Frazer RS, Genereux GP, eds. Diagnosis of diseases of the chest. Philadelphia: WB Saunders, 1991:2647-771.
35. Ueda T, Ohta K, Suzuki N et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992;146:266-8.
36. Campbell EV, Harris B, Avioli LV. Idiopathic pulmonary fibrosis. Arch Intern Med 1981;141:771-4.
37. Dolcher MP, Marchini B, Sabbatini A et al. Autoantibodies from mixed cryoglobulinemia patients bind glomerular antigens. Clin Exp Immunol 1994;96:317-21.
38. Ferri C, Longombardo G, La Civita L et al. Hepatitis C virus as common cause of mixed cryoglobulinaemia and chronic liver disease. J Intern Med 1994;236:31-6.
39. Lenzi M, Johnson PJ, McFarlane IG et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991;ii:277-80.
40. Moriya K, Yasuda K, Koike K et al. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C. J Gastroenterol 1994;29:514-7.